0000899243-19-017229.txt : 20190617
0000899243-19-017229.hdr.sgml : 20190617
20190617185910
ACCESSION NUMBER: 0000899243-19-017229
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190613
FILED AS OF DATE: 20190617
DATE AS OF CHANGE: 20190617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CRANSTON MARY B
CENTRAL INDEX KEY: 0001104268
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37609
FILM NUMBER: 19902365
MAIL ADDRESS:
STREET 1: C/O VISA INC.
STREET 2: P.O. BOX 8999
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94128-8999
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MyoKardia Inc
CENTRAL INDEX KEY: 0001552451
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 455500552
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-741-0900
MAIL ADDRESS:
STREET 1: 333 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-06-13
0
0001552451
MyoKardia Inc
MYOK
0001104268
CRANSTON MARY B
C/O MYOKARDIA, INC.
333 ALLERTON AVENUE
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Stock Option (Right to Buy)
47.17
2019-06-13
4
A
0
6600
0.00
A
2029-06-12
Common Stock
6600
6600
D
Restricted Stock Units
2019-06-13
4
A
0
2300
0.00
A
Common Stock
2300
2300
D
The shares subject to this option shall vest and become exercisable in 12 equal monthly installments with the first installment on July 13, 2019, such that all of the underlying shares shall be vested on June 13, 2020, subject to the Reporting Person's continued service on the Issuer's Board of Directors. This option is subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a Sale Event (as defined in the Issuer's 2015 Stock Option and Incentive Plan, as amended).
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in a single installment on the first anniversary of the grant date, such that all of the underlying shares shall be vested on June 13, 2020, subject to the Reporting Person's continued service on the Issuer's Board of Directors. The shares of Common Stock underlying the RSUs are subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a Sale Event (as defined in the Issuer's 2015 Stock Option and Incentive Plan, as amended).
/s/ Cynthia Ladd, as Attorney-in-Fact
2019-06-17